AR and metastatic neoplasm: Finally, we have evaluated the performance of these transcripts as a signature in discriminating between benign tissue samples, localised PCa and metastatic disease in an additional dataset generated by Grasso et al. ROC curves reveal that the signature exceeds the performance of ERG, KLK3 or the AR as a classifier.